Life Sciences | Europe


Morrison & Foerster provides a full range of services to clients in the biotechnology, medical device, pharmaceutical and healthcare industries. The firm's Life Sciences Group has over 180 lawyers in offices around the world, working with life sciences companies at every phase of their growth cycle, including formation and financing of early-stage ventures; start-up technology transfer; structuring and negotiating licenses, research and development collaborations, and other technology transactions; corporate partnerships and collaboration; planning and developing intellectual property portfolios; mergers and acquisitions; initial public offerings and follow-on securities offerings; protecting and defending intellectual property rights; and siting, permitting, developing and financing new research and manufacturing facilities.

Our European practice offers unrivalled transactional expertise. We provide advice on all aspects of corporate and commercial transactions and issues relevant to life sciences companies, their investors and advisors.

“The group at Morrison & Foerster has a strong pedigree advising businesses of all sizes within the life sciences sector …"
(Chambers UK 2013)

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2017 Morrison & Foerster LLP. All rights reserved.